Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Melanoma 7Carcinoma, Non-Small-Cell Lung 7Colorectal Neoplasms 6Stomach Neoplasms 5Pancreatic Neoplasms 5Carcinoma, Renal Cell 5Uterine Cervical Neoplasms 4Squamous Cell Carcinoma of Head and Neck 4Rectal Neoplasms 4Neoplasms 4Nasopharyngeal Carcinoma 4Neoplasm Metastasis 3Endometrial Neoplasms 3Triple Negative Breast Neoplasms 2Skin Neoplasms 2Prostatic Neoplasms 2Ovarian Neoplasms 2Lung Neoplasms 2Glioblastoma 2Esophageal Squamous Cell Carcinoma 2Advanced Solid Tumors 2von Hippel-Lindau Disease 1Thyroid cancer, follicular 1Thyroid cancer, Hurthle cell 1Thyroid Neoplasms 1Thyroid Cancer, Papillary 1Stomach Adenocarcinoma 1Solid Tumors 1Solid Tumor, Adult 1Solid Tumor 1

Interventions

Injections 13pembrolizumab 10tislelizumab 9toripalimab 6atezolizumab 4Nivolumab 4Carboplatin 3trastuzumab deruxtecan 2olaparib 2lenvatinib 2Pemetrexed 2Paclitaxel 2Oxaliplatin 2Gemcitabine 2Fluorouracil 2Docetaxel 2Cyclophosphamide 2Cisplatin 2Cetuximab 2Bevacizumab 2zimberelimab 1talazoparib 1spartalizumab 1sotorasib 1serabelisib 1penpulimab 1niraparib 1nedaplatin 1mirdametinib 1fludarabine phosphate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Advanced Solid Tumor × spartalizumab × 1 year × Clear all
NCT05978102 2025-07-23

A Dose Escalation and Dose Expansion Clinical Study of STI-7349 in Subjects With Advanced Solid Tumors

The Fourth Affiliated Hospital of Zhejiang University School of Medicine

Phase 1/2 Recruiting
183 enrolled
Other solid neoplasm

Advanced Solid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡